Ligand Pharmaceuticals Q3 Royalty Revenue Jumps 51%
Story updates
11:23:05 AM UTC
SquawkNews
Ligand Pharmaceuticals rutscht im dritten Quartal 2026 mit 28.5 Millionen US-Dollar in die Verlustzo
11:23:31 AM UTC
SquawkNews
Ligand reported third-quarter 2026 total revenues and income of $78.7 million, while royalty revenue increased 51% year over year to $70.3 million. The company posted a GAAP net loss of $28.5 million and adjusted diluted EPS of $2.67. Ligand raised its full-year adjusted diluted EPS guidance to $9…